>>12652299It makes me wonder about security in these facilities. How many people are involved in the filling process? How many in the production of the vaccine itself? There are competing needs here. For security reasons (and economic ones), you'd want to minimize the number of people who have access to the process to prevent tampering and human error but at the same time, you want to maximize the ability to catch contamination issues, which means adding more people to the QA process.
Since it's a new vaccine that needs to be kept at far lower temperatures than other vaccines, they're going to want to go heavy on the QA side but at the same time, they're under enormous pressure to churn out as many vaccine doses as possible. If mold or particulate contamination is going to kill 500 people receiving the vaccine but stopping the production to address those issues causes a week of delays in production, which allows 50,000 more people to die from not being vaccinated, which way do you go?
